According to IMARC Group’s latest report, titled “Next-Generation Sequencing (NGS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the global next generation sequencing market is expanding at double digit growth rate and is expected to grow at a CAGR of 17% during 2020-2025.Next-generation sequencing refers to the process of determining the sequence of nucleotides in DNA.It involves various procedures, such as sequencing by synthesis (SBS), ion semiconductor sequencing, nanopore sequencing, and single-molecule real-time (SMRT) sequencing.Next-generation sequencing is a cost-effective solution that offers faster and highly precise results.This enables the analysis of millions of DNA molecules, which facilitates research activities in the fields of personalized and genetic medicines, agriculture and animal research, and clinical diagnostics.The growing prevalence of chronic diseases, such as cancer, along with several technological advancements in the field of medical sciences are primarily driving the next generation sequencing market.Furthermore, due to the widespread utilization of liquid biopsies in cancer diagnosis, there has been an increasing demand for NGS technologies.These technologies utilize cell-free circulating tumor DNA (ctDNA) as a non-invasive cancer biomarker for real-time cancer monitoring and detection.
The global active pharmaceutical ingredient (API) market size is expected to reach USD 306.1 billion by 2027 according to a new study by Polaris Market Research.The report “Active pharmaceutical Ingredient (API) market Share, Size, Trends, Industry Analysis Report, By Product Type (Monoclonal Antibodies, Immunoglobulin, Cytokines, Insulin, Peptide Hormones, Blood Factors, Peptide Antibiotics, Vaccines, Small Molecule Antibiotics, Highly Potent Active Pharmaceutical Ingredient (HPAPI), and Others); By Form (Aqueous, Non-Aqueous Liquid, and Dry Powder); By Manufacturer Type (Captive, and Merchant); By Application (Cardiology, Oncology, CNS & Neurology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, and Others), By Regions; Segment Forecast, 2020 –2027”gives a detailed insight into current market dynamics and provides analysis on future market growth.Active Pharmaceutical Ingredient (API) is a substance involved in the finished pharmaceutical product (FPP), aimed to enhance the pharmacological activity or have direct impact in the cure, mitigation, diagnosis, treatment of disease or in modifying, correcting or restoring physiological functions in the human body.The prominent factors favoring the global market include the sudden outbreak of novel corona virus, which is rapidly escalating the demand for pharmaceuticals and thereby fueling the overall market growth.Additionally, rise in aging population, rising cases of cardiovascular diseases, cancer, AIDs, other infectious diseases, are further contributing to augmenting demand for APIs that are used in drugs.Moreover, rising incidence of cardiovascular, oncology, diabetes and lifestyle diseases coupled with rising geriatric populace is furthermore surging the overall demand for the global market.Request for sample copy of this report @ https://www.polarismarketresearch.com/industry-analysis/active-pharmaceutical-ingredients-market/request-for-sampleMarket participants such as AbbVie Inc., Albemarle Corporation, AstraZeneca, Aurobindo Pharma, Boehringer Ingelheim, Bristol-Myers Squibb, Cipla Inc., Dr. Reddy’s Laboratories Ltd., ELI Lilly and Company, F. Hoffmann-La Roche, GlaxoSmithKline PLC, Lonza Group, Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer, Inc., Sanofi, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd. are some of the key players operating in the global market.Players in the market are focusing on developing active pharmaceutical Ingredient to suffice the rising demand of critical drugs for the treatment of numerous diseases.For the treatment of various diseases such as cancer, HIV, arthritis, Hepatitis-B, diabetes, cardiovascular diseases, Aids and various others, which are responsible for the majority of deaths across the globe, the innovation and demand for pharmaceuticals has witnessed elevated graph over the few decades.
Summary - A new market study, titled “ Global China Contract Research Organization (CRO) Market (Clinical, Pre-clinical & Dis…December 14, 2020 China CRO market value is anticipated to reach US$27.04 billion in 2024, growing at a CAGR of 27.06%, for the period spanning from 2020 to 2024.The factors such as increasing biologics sales, rising geriatric population, growing investment in healthcare sector, accelerating number of innovative drug IND filings, inclining drug research and development expenditures and unmet treatment needs are expected to drive the market.However, growth of the industry would be challenged by the U.S. and China trade tensions, growing competition and regulatory compliance.A few notable trends include increasing consolidation activities, adoption of AI technology and emergence of e-clinical technology.During previous years, CRO industry has grown from limited clinical trial services provider to a full-service industry characterized by broad relationships with clients and service offerings that encompass the entire drug development process.In addition, CROs provide services that generate high quality and timely data in support of applications for regulatory approval of new drugs or reformulations of existing drugs as well as marketing claims.They also leverage selected information technologies and procedures to efficiently capture, manage and analyze the large streams of data generated during a clinical trial.Clinical services are the most consumed CRO service owing to growth in large molecule drug development outsourcing activities by drug-maker.
The report covers an overview of the industry along with a detailed explanation that provides a lot of insight.The report also analyzes the production as well as management technology in various end-user industries.An in-depth study in some new and prominent industry trends, analysis of the competition and regional analysis that is very detailed have been included in the report of the Small Molecule API market for the review period of 2020 – 2027.There are many different factors that have caused the quick expansion of the Small Molecule API market.In addition to the above, government initiatives, as well as the competitive landscape that exists in the Small Molecule API market through the forecast period, has been analyzed.Ask for report free sample with complete TOC and list of tables/figures @ https://www.datalibraryresearch.com/sample-request/small-molecule-api-market-2137Global Small Molecule API Market Key Companies:Allergan Plc,Aurobindo Pharma,Albemarle Corporation,Reddy’s Laboratories Ltd,Glaxosmithkline Plc,Cambrex Corporation,Lonza,Merck Sharp & Dohme Corp.,Mylan N.V.Novartis AGThe base year of the study is 2020 and the forecast period stretches all the way till 2027.This has led to the creation of a strong understanding of the market for the upcoming years.In addition to this, different latent growth factors, opportunities and restraints are evaluated for this advanced study and suggestions are made for the market that pertains to the forecast period.SegmentationThe Small Molecule API market covers different regions such as North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa.
Roots Analysis has done a detailed study on STING Pathway targeting therapeutics and Technologies, 2020-2030, covering key aspects of the industry and identifying future growth opportunities.To order this 310+ page report, which features 150+ figures and 200+ tables, please visit this link Key Market Insights Many small / macro molecule-based STING pathway modulators are currently being evaluated as monotherapies as well as in combination with other drugsThe pipeline features candidates targeting different therapeutic areas and designed for administration through a variety of routes; majority of such therapeutics are being developed as third-line and second-line treatmentsIn recent years, several well funded start-ups have entered this field of research, and are gradually developing proprietary products based on the STING pathway for the treatment of a variety of indicationsIn addition, a number of big pharmaceutical players have also partnered with developers focused on STING targeting molecules in order to expand their respective capabilities in this upcoming field of pharmacologyPublished scientific literature indicates that both industry and academic players have made equal contributions to the innovation in this field; the major focus of such studies is presently on anti-cancer therapeuticsSeveral non-profit organizations have extended financial support to aid research efforts in this domain; the current focus appears to be on drug development and disease modelling studiesForeseeing a lucrative future, private and public investors have invested capital worth over USD 2.5 billion, across more than 80 instances, in companies involved in STING pathway researchThe rising interest is also reflected in recent partnership activity, involving the active participation of both international and indigenous companies; majority of the deals have been focused on novel technology platformsMultiple companies are developing novel technology platforms for enhancing the research and development of STING pathway targeting therapeuticsTechnology developers are expected to continue relying on licensing agreements involving different STING modulators as their primary source of revenues in the foreseen future For more information, please visit https://www.rootsanalysis.com/reports/sting-pathway-targeting-therapeutics-and-technologies-market.html Table of Contents PREFACE1.1.Analysis by Number of Grants7.3.2.Analysis by Type of Recipient Organization7.3.10 Regional Distribution of Grant Recipients7.3.11 Most Popular Recipient Organizations: Analysis by Number of Grants and Amount Invested7.3.12.Analysis by Type of Publication10.3.2.Global STING Pathway Targeting Technologies Market, 2020-203013.3.1.
STING, having generated significant interest within the medical research community, is currently considered one of the fastest growing areas of cancer immunotherapy and is being pursued by several large pharmaceutical companies Roots Analysis is pleased to announce the publication of its recent study, titled, “STING Pathway Targeting Therapeutics and Technologies, 2020-2030.” The report features an extensive study of the current market landscape and future potential of these therapeutics and affiliated technologies, over the next decade.This study focuses specifically on small molecule STING modulators.The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain.In addition to other elements, the study includes:A detailed assessment of the current market landscape of therapeutics targeting STING Pathway.A detailed assessment of the current market landscape of various technology platforms that are being actively used for the development of STING modulators.Detailed profiles of developers of therapeutics targeting STING pathway (shortlisted on the basis of phase of development of pipeline products).An in-depth analysis of more than 280 grants that have been awarded to research institutes engaged in STING pathway targeting therapeutics-related projects.An analysis of the initiatives of big pharma players engaged in this domain.An analysis of the start-ups / small players (established in the last ten years, less than 50 employees) engaged in the development of STING pathway targeting therapeutics.A detailed publication analysis of more than 300 peer-reviewed, scientific articles that have been published during the period 2019 - Q1 2020.An analysis of the partnerships that have been established in this domain, in the recent past.An analysis of the investments made in this domain.A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)Types of PaymentUpfront PaymentsMilestone Payments Type of STING ModulatorAgonistAntagonist Key Therapeutic Area(s)Oncological DisordersInflammatory DisordersInfectious DiseasesOthers Route of AdministrationIntratumoralIntravenousOralSubcutaneousOthers Type of MoleculeNon-nucleotideCyclic DinucleotideLive BiotherapeuticsOncolytic PeptidesSynthetic PeptidesOthers Key Geographical RegionsNorth AmericaEuropeAsia-Pacific Key companies covered in the reportAduro BiotechBristol Myers SquibbEisaiGlaxoSmithKlineImmuneSensor TherapeuticsMerckNoxopharmSpring Bank PharmaceuticalsSynlogic For more information please click on the following link:https://www.rootsanalysis.com/reports/sting-pathway-targeting-therapeutics-and-technologies-market.html Other Recent OfferingsNuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030Global Psychedelic Therapeutics Market by Type of Psychedelic Substance (Ketamine, Psilocybin, MDMA and Others), by Origin (Natural and Synthetic), by Type of Therapy (Monotherapy, Combination and Others), by Route of Administration (Oral, Intravenous, Intranasal and Others) and by Key Geographies (North America, Europe and Asia- Pacific and rest of the world): Industry Trends and Global Forecasts, 2020-2030Endocannabinoid System Targeted Therapeutics Market, 2020-2030 About Roots AnalysisRoots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry.The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.
To order this detailed 600+ page report, please visit this link Key InclusionsAn overview of the current market landscape of companies engaged in developing and / or manufacturing autoinjectors, providing information on the usability (disposable and reusable), type of primary drug container (cartridge, syringe and vial), volume of container, type of dose (fixed and variable), route of administration (intradermal, intramuscular and subcutaneous), actuation mechanism (automatic and manual) and feedback mechanism integrated in the device.It also provides details on the developers, highlighting their year of establishment, company size (small-sized, mid-sized and large), location of headquarters and location of manufacturing facilitiesInformation on companies that are developing drugs in combination with autoinjectors, featuring details on initial year of approval (for marketed products), phase of development, usability of the device, route of administration (intracavernous, intramuscular and subcutaneous), type of drug molecule (antibody, peptide, protein and small molecule), dose strength, therapeutic area and other approved dosage forms (for marketed products).In addition, the section provides details on the company, including year of establishment, company size and location of headquartersA competitiveness analysis of various disposable and reusable autoinjectors, taking into consideration supplier power (based on year of establishment and company size) and key product specifications, such as route of administration, primary drug container used, injector actuation mechanism, type of dose and user friendliness of the product.An in-depth analysis of the various patents that have been filed / granted related to autoinjectors, till August 2019, highlighting details on key parameters, such as type of patent, publication year, issuing authority, CPC classification, emerging focus areas and leading industry players (on the basis of number of patents).It also includes a detailed patent benchmarking and an insightful valuation analysis.A detailed brand positioning analysis of leading industry players (shortlisted on the basis of strength of product portfolio), highlighting the current perceptions regarding their proprietary brands by taking into consideration several relevant aspects, such as strength and diversity of product portfolio, route of administration, actuation mechanism, geographical presence / reach and supplier power of each company.A list of marketed drugs / therapies and pipeline candidates that are likely to be developed in combination with autoinjectors in the near future, shortlisted on the basis of an in-depth analysis that takes into consideration various relevant parameters, such as route of administration, type of drug molecule, target indications, other available dosage forms (for approved drugs) and historical annual sales information (for approved drugs).A list of key opinion leaders (KOLs) within this domain who were short-listed based on their contributions (such as involvement in clinical trials and being mentioned in patent applications); it features a schematic world map representation, highlighting the geographical locations of eminent scientists / researchers engaged in this domain.Detailed case studies on the most commonly targeted indications, covering history of development and detailed description of the approved autoinjector products, along with their respective mechanisms of action and historical sales records; the study provides a list of all the drugs that are currently being delivered via autoinjectors.A case study on the role of CMOs offering services for drug delivery devices; it features a list of service providers, highlighting the various types of services offered for different types of drug-delivery devices.A SWOT analysis capturing the key parameters and trends that are likely to influence the future of autoinjectors market.Elaborate profiles of autoinjector manufacturers that have more than three devices in their respective product portfolios; each profile features an overview of the company, its financial information (if available), information on its product portfolio, autoinjector device specifications, collaborations, recent developments and an informed future outlook.Additionally, the report includes brief profiles of emerging players that have been established in the past decade.The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:UsabilityDisposableReusableRoute of administrationSubcutaneousIntramuscularType of moleculeAntibodyPeptideProteinSmall moleculeTherapeutic indicationAnaphylaxisDiabetesMigraineMultiple sclerosisRheumatoid arthritisOther indicationsKey geographical regionsNorth AmericaEuropeAsia-PacificRest of the World The report features inputs from eminent industry stakeholders, according to whom autoinjectors address several limitations of conventional parenteral drug delivery process, by preventing accidental needle-stick injuries, dosing errors and are preferred even by patients with trypanophobia.
Roots Analysis has done a detailed study on Global Autoinjectors Market (3rd Edition), 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.To order this 600+ page report, which features 360+ figures and 350+ tables, please visit this link Key Market Insights Currently, several companies claim to be engaged in the development / manufacturing of various types of autoinjectors, most of which are disposable systems that use prefilled syringes as primary drug containersAbout 90 autoinjector-based combination products have been approved for the treatment of a variety of clinical conditions; the subcutaneous route being the preferred mode of drug delivery via such devicesIn order to gain a competitive edge in the market, many autoinjector manufacturers are focusing on the integration of advanced features into their respective products and affiliated offeringsOver time, more than 4,600 patents have been filed / granted related to autoinjectors and affiliated products; most of the new intellectual property is related to additional features, such as safety locks and device connectivityEminent scientists from renowned organizations and academic institutions across the world have made valuable contributions to this field, in terms of leading clinical research efforts and developing novel technologiesSeveral autoinjector developers have established strong brand positions in different geographies; the focus, in the near term, is likely to be on further enhancing device features for better disease management and improved patient complianceAn evaluation of 200+ marketed and pipeline products revealed that a variety of drugs / product candidates are likely to be considered for administration via autoinjectors in the near futureCase Study: Owing to the complexities associated with the manufacturing and assembly of autoinjector drug delivery systems, industry players are known to frequently engage the services of contract service providersCurrently, disposable autoinjector products for small molecule drugs dominate the market; however, in the foreseen future, the demand for reusable devices is anticipated to witness significant growthGiven the recent approvals and presence of multiple drug candidates in later stages of development, the market opportunity is likely to be distributed across different therapeutic areas, routes of administration and geographies For more information, please visit https://www.rootsanalysis.com/reports/view_document/autoinjectors-market/293.html Table of Contents PREFACE1.1.Types of Self- Administration Devices3.6.1.Based on Number of Chambers22.214.171.124.2.2.Reusable Autoinjectors BRAND POSITIONING ANALYSIS OF KEY INDUSTRY PLAYERS7.1 Chapter Overview7.2.
Even it goes right for planets, asteroids, and stars.The images show that for the last two decades, the nebula is fading away.Such events are strange, as, in the universe, it takes to complete more than millions of years to complete a process.It is one of the most remarkable observatories of our time, along with the Spitzer Space Telescope, Compton Gamma Ray Observatory, and the Chandra X-ray Observatory.The telescope has a 2.4-meter (7.9 ft) Cassegrain mirror of Ritchey–Chrétien design and four main instruments that observe the electromagnetic spectrum in the ultraviolet, visible, and near-infrared regions.It has done more than 1.3 million observations since its mission began in 1990.Instruments in Hubble TelescopeHigh-speed photometerNear-infrared camera and multi-object spectrometer (NICMOS)Space telescope imaging spectrographWide-field and planetary cameraCosmic origins spectrograph (COS)Corrective optics space telescope axial replacement (COSTAR)Faint object cameraFaint object spectrographFine guidance sensorAchievements of Hubble Space TelescopeDetermining the age of the universe.Understanding the formation of planets.Discovery of the first organic molecule on a planet outside our solar system.Discovery of the four Plutonian moons.Detecting a distant supernova suggesting that the universe only recently began speeding up.About Stingray NebulaIt is the youngest planetary known nebula and situated in the southern constellation Ara (the Altar).
Processing and maintaining of data are the two major fields in smart healthcare systems, and any mistake can lead to disasters, AI reduces the risks of any absurd mistakes, which makes it a useful tool for the field.After observing the AI system's capacities and capabilities, the governments are adopting them for which they have increased the healthcare budgets and will accelerate the market's growth pace.As this is a software-powered system, the companies are regularly and rigorously working towards upgrading the systems with the latest software and solutions.Download Sample Table of Content PDF of COVID-19/CoronaVirus Impact Analysis of AI in drug discovery market 2020 @https://www.marketresearchfuture.com/sample_request/9393 According to Market Research Future (MRFR), the global AI in drug discovery market is poised to create a valuation of USD 2,015.1 MN by 2025, registering a massive 40.8% CAGR throughout the predicted years (2019 – 2025).Moreover, rising numbers of start-ups operating in the AI spectrum drug discovery foster market growth.Also, the lack of adequate infrastructure in low economic countries obstructs the growth of the market.By End-User : Pharmaceutical & Biotechnology Companies, Research Centers and Academic & Government Institutes, Contract Research Organizations, and others.
Next Generation Sequencing Market is anticipated to reach USD 21.4 billion by 2025.NGS market is expected to show a tremendous growth on account of its wide applications in the treatment of cancer.NGS is the process of identifying accurate order of nucleotides within a RNA or a DNA molecule.Advancement of NGS has helped biological and medical discovery and research.Further, the overall cost of genome sequencing is expected to reduce drastically on account of rapid development through research and innovation.The need for effective diagnosis for cancer and high growing usage of combinational biomarkers are other factors contributing to the growth of the market in recent years.
Exhaustive research was conducted to collect information on the market as well as its peer and parent markets.The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.According MarketsandMarkets Research – The Global Depth Filtration Market is projected to reach USD 2.9 billion by 2025 from USD 1.7 billion in 2019, at a CAGR of 9.0% during the forecast period.The Key Factors Who will Drives the Market Growth?Increasing adoption of single-use technologiesFocus on developing large-molecule bio-pharmaceuticalsAdvantages such as low cost and ease of use are driving the uptake of depth filtersIncreased preference of synthetic depth media over naturally derived mediaRecent Developments in Depth Filtration Industry:In 2019, Sartorius opened manufacturing operations in Yauco, Puerto Rico, to increase its production capacity and deliver a wider array of products to its American customers directly.In 2019, Merck expanded its distribution capacity in Gillingham, UK.In 2019, Parker Bioscience Filtration, a part of Parker Hannifin, expanded its facilities at Birtley, UKRequest Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=143876285Market Segmentation in Detailed:Based on the product, is segmented into cartridge filters, capsule filters, filter modules, filter sheets, plate and frame filters, accessories, and other products (includes caps, pads, pods, syringes, bags, and discs).The cartridge filters segment accounted for the largest share of the global depth filtration market in 2019.This can be attributed to the high dirt-holding capacity and long service life of these products.Based on media, the depth filtration market is broadly segmented into diatomaceous earth (DE), activated carbon, cellulose, perlite, and other media (glass fibers, quartz, borosilicate, and resin binders).The DE filters segment accounted for the largest share of 41.3% of the global depth filtration market in 2018.The large share of this segment is attributed to the high-quality filtration offered by DE and its wide range of applications in the pharmaceutical and biopharmaceutical industry.Based on the application, is segmented into final product processing, cell clarification, raw material filtration, diagnostics, and viral clearance.
Roots Analysis has done a detailed study on Drug Repurposing Service Providers Market, 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.To order this 250+ page report, which features 100+ figures and 140+ tables, please visit this link Key Market Insights More than 60 industry players across the world are presently engaged in providing services for the repurposing of therapeuticsThe dataset features a variety of CRO, big data / analytics and technology-based service providers, offering repurposing services by using different type of repurposing approaches and drug moleculesOver 1,700 discontinued clinical studies of therapeutics can be considered as potential candidates for repurposingIn the pursuit of obtaining an edge within this emerging and highly competitive market landscape, service providers are actively exploring the therapeutic potential of the existing approved drugs by providing the necessary support to drug developers in identifying / predicting prospective drug candidates for repurposing.Over time, recent initiatives have been undertaken by big pharma players across the world for the discovery and development of repurposed drugsSeveral organizations have extended financial support to aid research efforts in this domain; the current focus is on investigation of novel immune checkpoint pathways / targets for coronavirus diseaseThe growing interest in this field is also reflected by the 10+ partnerships have been signed in the last three years, involving both international and indigenous stakeholdersThe future market, based on the revenue generation potential of repurposed drugs, is anticipated to be distributed across different disease areas and key geographical regionsIn the long term, the opportunity is likely to be segmented across type of repurposing approaches, purpose of repurposing and type of drug molecule For more information, please visit https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html Table of Contents PREFACE 1.1.Drug Repurposing Service Providers: List of Non-Profit Organizations5.3.List of Drug Repurposing Initiatives of Big Pharma Players8.2.1.Analysis by Number of Initiatives8.2.2.Discontinued Clinical Trials: Oncology Disorders126.96.36.199.
Intradermal antigen (IgE) neutralization assays can measure the amount of neutralizing antibodies in the blood, and they provide information about the type of antigens recognized by the immune system.Intradermal antibody immunity is a passive protective mechanism where antibodies or plasma cells from the peripheral immune system are detected and bind to antigens present on the surface of virus particles.However, some viruses cause immune suppression and the absence of antigens may not cause the same reaction.Intradermal antibody (IA) neutralization tests are used to determine if a patient has a positive response to a vaccination or if they have been vaccinated but are unresponsive to the vaccine.Interferon Neutralization TestInterferon neutralization tests measure antibody responses to interferons.Interferons are proteins produced by the interferon regulatory factor and they have the ability to attach to the receptor of the target cells.When interferon binds to a receptor, it activates an effector molecule, which in turn causes T-cells to produce antibodies to attack the invader.The exact measurement of the IAA neutralization test requires several factors including antigen type, concentration of intracellular antibodies, and duration of infection.Monoclonal Antibody Test (MAb)Another test for the measurement of IgE immunity against infection is the monoclonal antibody test (MAb).
New York, NY 08 Dec 2020: The global Epoxy Resin Market size is expected to reach USD 11.28 billion by 2026 according to a new study by Polaris Market Research.The report “Epoxy Resin Market Share, Size, Trends, Industry Analysis Report By Raw Material (DGBEA, DGBEF, Novolac, Aliphatic, Glycidylamine, Hardener); By Application (Paints & Coatings, Wind Turbine, Composites, Construction, Electrical & Electronics, Adhesives, and Others); By Regions, Segment Forecast, 2020 – 2026” gives a detailed insight into current market dynamics and provides analysis on future market growth.Epoxy resins are significant raw materials to various end-use chemical compounds where each significant molecule is attributed a unique opportunity to convert to a useful thermosetting product.The major end-user industries for epoxy resins include electronics and paints and coatings followed by adhesives, composites, wind turbines and others.Epoxy resins find extensive use in powder coatings applied to automotive and appliances parts, in solvent-dipped coatings applied to substrates in corrosive environment and water-based coatings as electrodepositing primers in automobiles.Request For Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/epoxy-resins-market/request-for-sampleEpoxy resins possess favorable properties such as high thermal stability, mechanical strength, resistivity, adhesion, electrical, mechanical and heat resistance that makes it ideal choice for use in laminates, jewelry and insulators.High performance composite demand will be fueled by tremendous growth in the commercial airplane market as well as emerging opportunities in applications such as wind turbines and pressure vessels.Increasing composites demand from the automotive and aerospace industries particularly in Europe and North America is expected to remain its key driving factor.